Paclitaxel, 5-fluorouracil, and folinic acid in metastatic breast cancer: BRE-26, a phase II trial

被引:0
|
作者
Johnson, DH
Paul, D
Hande, KR
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S22 / S25
页数:4
相关论文
共 50 条
  • [41] SEQUENTIAL ADMINISTRATION OF CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL, AND FOLINIC ACID AS SALVAGE TREATMENT IN METASTATIC BREAST-CANCER
    PRONZATO, P
    AMOROSO, D
    ARDIZZONI, A
    BERTELLI, G
    CANOBBIO, L
    CONTE, PF
    CUSIMANO, MP
    FUSCO, V
    GULISANO, M
    LIONETTO, R
    REPETTO, L
    ROSSO, R
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1987, 10 (05): : 404 - 406
  • [42] PHASE-II TRIAL OF 5-FLUOROURACIL AND HIGH-DOSE FOLINIC ACID IN ADVANCED RENAL-CELL CANCER
    ZANIBONI, A
    MARPICATI, P
    FERRARI, V
    SIMONCINI, E
    MONTINI, E
    MARINI, G
    JOURNAL OF CHEMOTHERAPY, 1989, 1 (05) : 350 - 351
  • [43] 5-FLUOROURACIL MONOTHERAPY VERSUS FOLINIC ACID AND 5-FLUOROURACIL IN ADVANCED COLORECTAL-CANCER - RESULTS OF A RANDOMIZED TRIAL
    STEINKE, B
    GUNTHER, E
    HIRSCHMANN, W
    SONDERN, W
    KONICZECK, KH
    WANDER, HE
    NATT, F
    WAGNER, T
    HINRICHS, HF
    ROTH, W
    ONKOLOGIE, 1993, 16 (04): : 252 - 259
  • [44] Phase II trial of oxaliplatin/irinotecan/5-fluorouracil/leucovorin for metastatic colorectal cancer
    McWilliams, Robert R.
    Goetz, Matthew P.
    Morlan, Bruce W.
    Salim, Muhammad
    Rowland, Kendrith M.
    Krook, James E.
    Ames, Matthew M.
    Erlichman, Charles
    CLINICAL COLORECTAL CANCER, 2007, 6 (07) : 516 - 521
  • [45] Phase II study of 5-Fluorouracil and high-dose folinic acid in combination with cyclophosphamide and mitoxantrone in advanced breast cancer
    Cavazzini, G
    Pagani, M
    Casarini, MB
    Aitini, E
    Cantore, M
    Rabbi, C
    Pari, F
    Paganini, G
    Zamagni, D
    Smerieri, F
    ANNALS OF ONCOLOGY, 1998, 9 : 27 - 28
  • [46] Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer
    Klaassen, U
    Wilke, H
    Seeber, S
    SEMINARS IN ONCOLOGY, 1996, 23 (05) : 32 - 37
  • [47] Efficacy and safety data of an outpatient regimen for pretreated metastatic or relapsed breast cancer (MBC): Vinorelbine, 5-Fluorouracil and Folinic Acid (FuFoINav) - a phase II study
    Eniu, A.
    Vitoc, C.
    Todor, N.
    Ghilezan, N.
    EJC SUPPLEMENTS, 2004, 2 (03): : 131 - 132
  • [48] A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer
    Lin, Chia-Chi
    Cheng, Ann-Lii
    Hsu, Chih-Hung
    Lu, Yen-Shen
    Hsu, Chiun
    Yeh, Kun-Huei
    Wu, Chen-Yao
    Huang, Chiun-Sheng
    Yang, Chih-Hsin
    ANTICANCER RESEARCH, 2007, 27 (1B) : 641 - 645
  • [49] CYCLOPHOSPHAMIDE PLUS EPIDOXORUBICIN AND 5-FLUOROURACIL WITH FOLINIC ACID AS A NOVEL TREATMENT IN METASTATIC BREAST-CANCER - PRELIMINARY-RESULTS OF A PHASE-II STUDY
    PALMERI, S
    GEBBIA, V
    RUSSO, A
    GEBBIA, N
    MELI, M
    RAUSA, L
    JOURNAL OF CHEMOTHERAPY, 1991, 3 (03) : 176 - 179
  • [50] FOLINIC ACID DOES IMPROVE 5-FLUOROURACIL ACTIVITY INVIVO - RESULTS OF A PHASE-III STUDY COMPARING 5-FLUOROURACIL TO 5-FLUOROURACIL AND FOLINIC ACID IN ADVANCED COLON CANCER-PATIENTS
    BOBBIOPALLAVICINI, E
    PORTA, C
    MORONI, M
    SPAGHI, A
    CASAGRANDA, I
    NASTASI, G
    JOURNAL OF CHEMOTHERAPY, 1993, 5 (01) : 52 - 55